Ashoka WhiteOak has dropped from Neogen Chemicals Limited's latest shareholder list, where it last held a 1.01 percent stake. This shift represents either a complete exit or a minor trim to below the 1 percent reporting threshold.
A manufacturer of bromine and lithium-based organic and organo-metallic compounds, Neogen Chemicals serves the pharmaceutical, agricultural chemicals, and engineering industries. Incorporated in 1991, the company specializes in producing specialized chemical intermediates and active pharmaceutical ingredients through vertically integrated manufacturing operations. Its diversified product portfolio addresses multiple industrial applications across pharmaceutical formulations, crop protection solutions, and specialized engineering chemical requirements.
India equity vehicle of WhiteOak Capital, the Singapore-headquartered manager founded in 2017 by Prashant Khemka, former CIO of Goldman Sachs Asset Management's India Equity and Global Emerging Markets businesses. WhiteOak group manages USD 10.8 bn (~Rs 96,000 cr) across SMAs and funds. Ashoka India Opportunities Fund ranks as the best-performing India UCITS fund since 2018 inception.
